肺功能受损老年人的衰弱状态转变:一项人群为基础的研究
该研究基于鹿特丹研究人群(平均年龄69.1±8.9岁),评估肺功能受损者(PRISm或COPD)的衰弱状态转变及衰弱评分对死亡的预测准确性。结果显示PRISm或COPD患者更易进展为衰弱且恢复较差,在COPD患者中将衰弱评分加入年龄、性别和吸烟状态可显著提高死亡预测准确性。
要点
- PRISm患者从健壮或衰弱前期向衰弱进展的风险升高,OR分别为2.2和2.6。
- PRISm和COPD患者从衰弱状态恢复的可能性较低,且更易进展至死亡。
- COPD患者中,在年龄、性别和吸烟状态基础上加入衰弱评分可显著提高死亡预测准确性。
核心结论
- PRISm或COPD的老年人更常发生衰弱且可逆性差,评估躯体衰弱有助于肺功能受损者的风险分层和预测寿命。
研究设计与样本
- 基于人群的鹿特丹研究,参与者平均年龄69.1±8.9岁,采用年龄、性别和吸烟状态校正的多项回归模型分析衰弱状态转变,并用c统计量评估衰弱评分对COPD患者死亡预测的准确性。
主要发现
- 与肺功能正常者相比,PRISm患者从健壮向衰弱转变的OR为2.2(1.2-4.2),p<.05;从衰弱前期向衰弱转变的OR为2.6(1.3-5.5),p<.01。
- PRISm患者从衰弱状态恢复的OR为0.4(0.2-0.8),p<.05;COPD患者为0.6(0.4-1.0),无统计学显著性。
- PRISm和COPD患者从任一衰弱状态进展至死亡的OR在1.1至2.8之间,p<.01。
- 在COPD患者中,将衰弱评分加入年龄、性别和吸烟状态后,死亡预测准确性显著提高,c统计量为90.5(82.3-89.8)对比77.9(67.2-88.6),p<.05。
关键数值与推荐
- PRISm定义为FEV1/FVC≥70%且FEV1<80%;COPD定义为FEV1/FVC<70%。
- 衰弱状态分为健壮、衰弱前期和衰弱三种。
临床怎么用
- 对PRISm或COPD的老年患者应评估躯体衰弱,以识别衰弱进展和死亡高风险人群。
- 衰弱评分可作为COPD患者死亡风险分层的辅助工具,帮助临床决策。
- 关注肺功能受损患者的衰弱可逆性差,需早期干预以延缓功能衰退。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The aging population and its burden on health care systems warrant early detection of patients at risk of functional decline and mortality. We aimed to assess frailty transitions and its accuracy for mortality prediction in participants with impaired spirometry (Preserved Ratio Impaired Spirometry [PRISm] or chronic obstructive pulmonary disease [COPD]). METHODS: In participants from the population-based Rotterdam Study (mean age 69.1 ± 8.9 years), we examined whether PRISm (forced expiratory volume in 1 second [FEV1]/forced vital capacity [FVC] ≥ 70% and FEV1 < 80%) or COPD (FEV1/FVC < 70%) affected frailty transitions (progression/recovery between frailty states [robust, prefrailty, and frailty], lost to follow-up, or death) using age-, sex- and smoking state-adjusted multinomial regression models yielding odds ratios (OR). Second, we assessed the diagnostic accuracy of frailty score for predicting mortality in participants with COPD using c-statistics. RESULTS: Compared to participants with normal spirometry, participants with PRISm were more likely to transit from robust (OR 2.2 [1.2-4.2], p < .05) or prefrailty (OR 2.6 [1.3-5.5], p < .01) toward frailty. Participants with PRISm (OR 0.4 [0.2-0.8], p < .05) and COPD (OR 0.6 [0.4-1.0], NS) were less likely to recover from their frail state, and were more likely to progress from any frailty state toward death (OR between 1.1 and 2.8, p < .01). Accuracy for predicting mortality in participants with COPD significantly improved when adding frailty score to age, sex, and smoking status (90.5 [82.3-89.8] vs 77.9 [67.2-88.6], p < .05). CONCLUSION: Participants with PRISm or COPD more often developed frailty with poor reversibility. Assessing physical frailty improved risk stratification for participants with impaired spirometry for predicting increased life years.
引用
- Wijnant SRA, Benz E, Luik AI, et al. Frailty Transitions in Older Persons With Lung Function Impairment: A Population-Based Study. J Gerontol A Biol Sci Med Sci. 2023. PMID: 36226677. doi:10.1093/gerona/glac202
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。